Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 403

1.

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications.

Blum Y, Meiller C, Quetel L, Elarouci N, Ayadi M, Tashtanbaeva D, Armenoult L, Montagne F, Tranchant R, Renier A, de Koning L, Copin MC, Hofman P, Hofman V, Porte H, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, de Reyniès A, Jean D.

Nat Commun. 2019 Mar 22;10(1):1333. doi: 10.1038/s41467-019-09307-6.

PMID:
30902996
2.

From the Editor's desk…: April 2018.

Moreau R, Bataller R, Berg T, Lotersztajn S, Zucman-Rossi J, Jalan R.

J Hepatol. 2019 Apr;70(4):583-586. doi: 10.1016/j.jhep.2019.02.001. No abstract available.

PMID:
30885295
3.

From the Editor's desk....: March 2019.

Moreau R, Bataller R, Berg T, Lotersztajn S, Zucman-Rossi J, Jalan R.

J Hepatol. 2019 Mar;70(3):335-338. doi: 10.1016/j.jhep.2018.12.020. No abstract available.

PMID:
30777172
4.

A European Academy of Rehabilitation Medicine Academic Debate: Describing Experienced Health on the Basis of the WHO's Model of Functioning (ICF) or on the Theory of Social Productivity?

Kiekens C, Didier JP, Malmivaara A, Negrini S, Gutenbrunner C.

J Rehabil Med. 2019 Feb 15. doi: 10.2340/16501977-2533. [Epub ahead of print]

5.

Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.

Adebayo Michael AO, Ko S, Tao J, Moghe A, Yang H, Xu M, Russell JO, Pradhan-Sundd T, Liu S, Singh S, Poddar M, Monga JS, Liu P, Oertel M, Ranganathan S, Singhi A, Rebouissou S, Zucman-Rossi J, Ribback S, Calvisi D, Qvartskhava N, Görg B, Häussinger D, Chen X, Monga SP.

Cell Metab. 2019 Jan 28. pii: S1550-4131(19)30002-6. doi: 10.1016/j.cmet.2019.01.002. [Epub ahead of print]

PMID:
30713111
6.

From the Editor's Desk: January 2019.

Moreau R, Bataller R, Berg T, Lotersztajn S, Zucman-Rossi J, Jalan R.

J Hepatol. 2019 Jan;70(1):1-4. doi: 10.1016/j.jhep.2018.11.002. No abstract available.

PMID:
30558742
7.

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.

Bayard Q, Meunier L, Peneau C, Renault V, Shinde J, Nault JC, Mami I, Couchy G, Amaddeo G, Tubacher E, Bacq D, Meyer V, La Bella T, Debaillon-Vesque A, Bioulac-Sage P, Seror O, Blanc JF, Calderaro J, Deleuze JF, Imbeaud S, Zucman-Rossi J, Letouzé E.

Nat Commun. 2018 Dec 7;9(1):5235. doi: 10.1038/s41467-018-07552-9.

8.

Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib.

Vanmechelen M, Lambrechts D, Van Brussel T, Verbiest A, Couchy G, Schöffski P, Dumez H, Debruyne PR, Lerut E, Machiels JP, Richard V, Albersen M, Verschaeve V, Oudard S, Méjean A, Wolter P, Zucman-Rossi J, Beuselinck B.

Clin Genitourin Cancer. 2018 Nov 16. pii: S1558-7673(18)30510-X. doi: 10.1016/j.clgc.2018.11.002. [Epub ahead of print]

PMID:
30527746
9.

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma.

Tranchant R, Quetel L, Montagne F, De Wolf J, Meiller C, De Koning L, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D.

Lung Cancer. 2018 Dec;126:15-24. doi: 10.1016/j.lungcan.2018.10.015. Epub 2018 Oct 16.

PMID:
30527180
10.

From the Editor's desk.…: December 2018.

Moreau R, Bataller R, Berg T, Lotersztajn S, Zucman-Rossi J, Jalan R.

J Hepatol. 2018 Dec;69(6):1209-1212. doi: 10.1016/j.jhep.2018.10.001. No abstract available.

PMID:
30449322
11.

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Dhanasekaran R, Nault JC, Roberts LR, Zucman-Rossi J.

Gastroenterology. 2019 Jan;156(2):492-509. doi: 10.1053/j.gastro.2018.11.001. Epub 2018 Nov 4. Review.

PMID:
30404026
12.

From the Editor's desk....: November 2018.

Moreau R, Bataller R, Berg T, Lotersztajn S, Zucman-Rossi J, Jalan R.

J Hepatol. 2018 Nov;69(5):993-995. doi: 10.1016/j.jhep.2018.09.001. No abstract available.

PMID:
30336889
13.

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.

Yang J, Trépo E, Nahon P, Cao Q, Moreno C, Letouzé E, Imbeaud S, Gustot T, Deviere J, Debette S, Amouyel P, Bioulac-Sage P, Calderaro J, Ganne-Carrié N, Laurent A, Blanc JF, Guyot E, Sutton A, Ziol M, Zucman-Rossi J, Nault JC.

Int J Cancer. 2019 Feb 1;144(3):533-544. doi: 10.1002/ijc.31910. Epub 2018 Nov 9.

PMID:
30289982
14.

Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma.

Calderaro J, Letouzé E, Bayard Q, Boulai A, Renault V, Deleuze JF, Bestard O, Franco D, Zafrani ES, Nault JC, Moutschen M, Zucman-Rossi J.

N Engl J Med. 2018 Sep 20;379(12):1178-1180. doi: 10.1056/NEJMc1805673. No abstract available.

PMID:
30231230
15.

From the Editor's Desk…: October 2018.

Moreau R, Bataller R, Berg T, Lotersztajn S, Zucman-Rossi J, Jalan R.

J Hepatol. 2018 Oct;69(4):759-761. doi: 10.1016/j.jhep.2018.08.001. No abstract available.

PMID:
30223946
16.

Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.

Calderaro J, Petitprez F, Becht E, Laurent A, Hirsch TZ, Rousseau B, Luciani A, Amaddeo G, Derman J, Charpy C, Zucman-Rossi J, Fridman WH, Sautès-Fridman C.

J Hepatol. 2019 Jan;70(1):58-65. doi: 10.1016/j.jhep.2018.09.003. Epub 2018 Sep 11.

PMID:
30213589
17.

Collective Shape Actuation of Polymer Double Emulsions by Solvent Evaporation.

Shi W, Didier JE, Ingber DE, Weitz DA.

ACS Appl Mater Interfaces. 2018 Sep 26;10(38):31865-31869. doi: 10.1021/acsami.8b13216. Epub 2018 Sep 12.

PMID:
30199225
18.

Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.

Gjorgjieva M, Calderaro J, Monteillet L, Silva M, Raffin M, Brevet M, Romestaing C, Roussel D, Zucman-Rossi J, Mithieux G, Rajas F.

J Hepatol. 2018 Nov;69(5):1074-1087. doi: 10.1016/j.jhep.2018.07.017. Epub 2018 Sep 5.

PMID:
30193922
19.

microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.

Roy S, Hooiveld GJ, Seehawer M, Caruso S, Heinzmann F, Schneider AT, Frank AK, Cardenas DV, Sonntag R, Luedde M, Trautwein C, Stein I, Pikarsky E, Loosen S, Tacke F, Ringelhan M, Avsaroglu SK, Goga A, Buendia MA, Vucur M, Heikenwalder M, Zucman-Rossi J, Zender L, Roderburg C, Luedde T.

Gastroenterology. 2018 Dec;155(6):1951-1966.e26. doi: 10.1053/j.gastro.2018.08.032. Epub 2018 Aug 27.

PMID:
30165047
20.

Corrigendum to "From the Editor's Desk August 2018" [J Hepatol 69 (2018) 265-268].

Moreau R, Bataller R, Berg T, Lotersztajn S, Zucman-Rossi J, Jalan R.

J Hepatol. 2018 Oct;69(4):987. doi: 10.1016/j.jhep.2018.08.002. Epub 2018 Aug 22. No abstract available.

PMID:
30143245

Supplemental Content

Loading ...
Support Center